OZ vs GMRE

For growth investors, Belpointe PREP, LLC (OZ) is the stronger pick with 18.

7% revenue growth year-over-year, versus -1. 8% for Global Medical REIT Inc. (GMRE). Global Medical REIT Inc. (GMRE) offers the better valuation at 115. 3x trailing P/E (595. 7x forward), making it the more compelling value choice. Analysts rate Global Medical REIT Inc. (GMRE) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Global Medical REIT Inc.

(GMRE) delivered a total return of -21. 4%, compared to -49. 3% for Belpointe PREP, LLC (OZ). Over 10 years, the gap is even starker: GMRE returned +308. 1% versus OZ's -49. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Belpointe PREP, LLC (OZ) is the lower-risk stock at 0.

31β versus Global Medical REIT Inc. 's 0. 48β — meaning GMRE is approximately 54% more volatile than OZ relative to the S&P 500. On balance sheet safety, Belpointe PREP, LLC (OZ) carries a lower debt/equity ratio of 59% versus 118% for Global Medical REIT Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Belpointe PREP, LLC (OZ) is pulling ahead at 18.

7% versus -1. 8% for Global Medical REIT Inc. (GMRE). On earnings-per-share growth, the picture is similar: Belpointe PREP, LLC grew EPS -62. 6% year-over-year, compared to -94. 6% for Global Medical REIT Inc.. Over a 3-year CAGR, OZ leads at 39. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Global Medical REIT Inc.

(GMRE) is the more profitable company, earning 4. 8% net margin versus -891. 8% for Belpointe PREP, LLC — meaning it keeps 4. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GMRE leads at 23. 6% versus -504. 3% for OZ. At the gross margin level — before operating expenses — GMRE leads at 78. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, GMRE (63.

5% yield) pays a dividend. OZ does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Global Medical REIT Inc.

(GMRE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 48), 63. 5% yield, +308. 1% 10Y return). Both have compounded well over 10 years (GMRE: +308. 1%, OZ: -49. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: OZ is a small-cap high-growth stock; GMRE is a small-cap income-oriented stock. GMRE pays a dividend while OZ does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.